Howard Horn
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 4SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 4,69696,295 held (−5%) | $24.92 | $117K | -37.9% |
| Jul 6SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 4,698100,991 held (−4%) | $33.13 | $156K | -53.3% |
| Jun 1SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 4,653105,689 held (−4%) | $23.77 | $111K | -34.9% |
| May 4SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 4,683110,342 held (−4%) | $24.90 | $117K | -37.8% |
| Apr 2SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 4,68380,351 held (−6%) | $20.97 | $98K | -26.2% |
| Mar 3SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 5,29089,788 held (−6%) | $22.80 | $121K | -32.1% |
| Mar 3SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 3,11986,669 held (−3%) | $22.54 | $70K | -31.3% |
| Mar 3SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 1,63585,034 held (−2%) | $22.40 | $37K | -30.9% |
| Feb 3SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 3,06188,935 held (−3%) | $23.56 | $72K | -34.3% |
| Jan 5SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 3,15091,996 held (−3%) | $22.84 | $72K | -32.2% |
| Dec 11SEC | RAREUltragenyx Pharmaceutical Inc. | Sell Plan | 3,08195,146 held (−3%) | $36.38 | $112K | -57.4% |
| Oct 14SEC | RAREUltragenyx Pharmaceutical Inc. | Sell | 7,94298,227 held (−7%) | $31.51 | $250K | -50.9% |
- Sell
CFO Howard Horn sold $117K of RARE at $24.92 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Howard Horn sold $156K of RARE at $33.13 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Howard Horn sold $111K of RARE at $23.77 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Howard Horn sold $117K of RARE at $24.90 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Howard Horn sold $98K of RARE at $20.97 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Howard Horn sold $121K of RARE at $22.80 — pre-scheduled 10b5-1 plan sale.